Obesity and Insulin Resistance

Obesity and insulin resistance are closely linked and contribute to the onset of type 2 diabetes and other metabolic disorders. This session will focus on the mechanisms that connect obesity and insulin resistance, with an emphasis on the latest research into their pathophysiology. Experts will explore how adipose tissue, inflammation, and insulin signaling contribute to the development of metabolic diseases.

Attendees will also learn about current and emerging therapeutic strategies to treat obesity and improve insulin sensitivity, including pharmacological interventions, lifestyle changes, and surgical options. Discussions will cover the challenges in managing these conditions, particularly in populations with high obesity rates, and how healthcare providers can improve treatment outcomes.

    Related Conference of Obesity and Insulin Resistance

    November 27-28, 2024

    14th World Congress on Endocrinology and Diabetes

    Paris, France
    February 24-25, 2025

    34th European Diabetes Congress

    London, UK
    March 10-11, 2025

    4th Global Summit on Physiology and Metabolism of Thyroid

    Singapore City, Singapore
    March 17-18, 2025

    5th European Endocrinology and Diabetes Congress

    Paris, France
    April 10-11, 2025

    5th World Congress on Endocrine and Diabetes

    Dubai, UAE
    April 10-11, 2025

    4th International Summit on Hormonal Disorders

    Dubai, UAE
    May 19-20, 2025

    6th World Summit on Diabetes

    Rome, Italy
    June 04-05, 2025

    4th World Congress on Diabetes and Pediatric Endocrinology

    Edinburgh, Scotland
    November 20-21, 2025

    21st World Congress on Endocrinology & Diabetes

    Aix-en-Provence, France

    Obesity and Insulin Resistance Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in